e.g. mhealth
Search Results (1 to 1 of 1 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 1 JMIR Formative Research
- 0 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Research Protocols
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR Public Health and Surveillance
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Similarly, fremanezumab was compared to group 4 to establish a baseline side effect profile for fremanezumab. We then compared the erenumab corpus against the fremanezumab corpus to ascertain any difference between the 2 medication side effect profiles. This is clinically relevant, as erenumab targets the CGRP receptor, while fremanezumab targets the CGRP ligand. We were interested to see whether there were fewer reports of specific adverse events with erenumab than with fremanezumab.
JMIR Form Res 2024;8:e58176
Download Citation: END BibTex RIS